127 related articles for article (PubMed ID: 9494586)
21. Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma.
de Vries H; Mulder NH; de Vries EG
Cancer; 2000 May; 88(9):2194-5. PubMed ID: 10813734
[No Abstract] [Full Text] [Related]
22. [Treatment of advanced pancreatic cancer with interferon alpha, tumor necrosis factor and 5-fluorouracil (preliminary report].
Muc M; Baranowski M; Braczkowski R
Wiad Lek; 1995; 48(1-12):198-202. PubMed ID: 9638240
[TBL] [Abstract][Full Text] [Related]
23. Large cell carcinoma with calcitonin and vasoactive intestinal polypeptide-associated Verner-Morrison syndrome.
Pratz KW; Ma C; Aubry MC; Vrtiska TJ; Erlichman C
Mayo Clin Proc; 2005 Jan; 80(1):116-20. PubMed ID: 15667039
[TBL] [Abstract][Full Text] [Related]
24. A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome.
Ichimura T; Kondo S; Okushiba S; Morikawa T; Katoh H
Int J Gastrointest Cancer; 2003; 33(2-3):99-102. PubMed ID: 14716055
[TBL] [Abstract][Full Text] [Related]
25. Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
Burch PA; Block M; Schroeder G; Kugler JW; Sargent DJ; Braich TA; Mailliard JA; Michalak JC; Hatfield AK; Wright K; Kuross SA
Clin Cancer Res; 2000 Sep; 6(9):3486-92. PubMed ID: 10999733
[TBL] [Abstract][Full Text] [Related]
26. [Vipoma. 9-year observations using currently available therapy methods].
Zimmermann K; Rapp T; Binder J; Frölich J; Bode JC
Dtsch Med Wochenschr; 1986 Feb; 111(8):298-301. PubMed ID: 2868874
[TBL] [Abstract][Full Text] [Related]
27. Continuous hepatic arterial infusion chemotherapy for liver metastasis from biliary tract and pancreatic cancers.
Kato Y; Tsuyuki A; Kikuchi K; Tokuyama J; Kurihara N; Kumamoto Y; Fujishiro Y; Ebinuma H
Anticancer Res; 2005; 25(1B):477-82. PubMed ID: 15816615
[TBL] [Abstract][Full Text] [Related]
28. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
Kornek GV; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
Br J Cancer; 2000 Jan; 82(1):98-103. PubMed ID: 10638974
[TBL] [Abstract][Full Text] [Related]
29. Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats.
Adeghate E
Neuropeptides; 1999 Jun; 33(3):227-35. PubMed ID: 10657496
[TBL] [Abstract][Full Text] [Related]
30. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients.
Marie J; Wakkach A; Coudray A; Chastre E; Berrih-Aknin S; Gespach C
J Immunol; 1999 Feb; 162(4):2103-12. PubMed ID: 9973484
[TBL] [Abstract][Full Text] [Related]
31. [Pancreatic vipoma with bizarre characteristics].
Bermejo F; Moreno L; Moreira V; Gisbert JP; González Palacios F; García López JL
Gastroenterol Hepatol; 1999 Mar; 22(3):132-5. PubMed ID: 10228323
[TBL] [Abstract][Full Text] [Related]
32. Streptozotocin treatment of a pancreatic tumour producing VIP and gastrin associated with Verner-Morrison syndrome.
Oberg K; Boström H; Fahrenkrug J; Dymling JF; Shaffalitsky de Muckadell OB; Lundqvist G
Acta Med Scand; 1979; 206(3):223-7. PubMed ID: 227234
[TBL] [Abstract][Full Text] [Related]
33. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
[TBL] [Abstract][Full Text] [Related]
35. Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial.
Takada T; Nimura Y; Katoh H; Nagakawa T; Nakayama T; Matsushiro T; Amano H; Wada K
Hepatogastroenterology; 1998; 45(24):2020-6. PubMed ID: 9951857
[TBL] [Abstract][Full Text] [Related]
36. Multimodal Treatment of Vasoactive Intestinal Polypeptide-producing Pancreatic Neuroendocrine Tumors with Liver Metastases.
Iwasaki M; Tsuchida K; Jinnai H; Komatsubara T; Arisaka T; Tsunemi M; Nakano M; Iijima M; Hiraishi H
Intern Med; 2017; 56(5):517-522. PubMed ID: 28250297
[TBL] [Abstract][Full Text] [Related]
37. [Pancreatic endocrine tumor with metastases and increase of alpha-fetoprotein. A case report].
Congy F; Pelletier S; Langlois P; Khayat D; Homsi T; Emerit J
Rev Med Interne; 1992 Nov; 13(6):451-3. PubMed ID: 1285358
[TBL] [Abstract][Full Text] [Related]
38. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
Dtsch Med Wochenschr; 2004 Mar; 129(13):689-92. PubMed ID: 15026965
[No Abstract] [Full Text] [Related]
39. [Non surgical treatment of pancreatic cancers].
Bleiberg H; Gerard B; Hendlisz A; Jagodzinski R
J Chir (Paris); 1997 Sep; 134(4):169-73. PubMed ID: 9499945
[TBL] [Abstract][Full Text] [Related]
40. Chemoradiation of unresectable pancreatic carcinoma: impact of pretreatment hemoglobin level on patterns of failure.
Morganti AG; Forni F; Macchia G; Valentini V; Smaniotto D; Trodella L; Balducci M; Cellini N
Strahlenther Onkol; 2003 Feb; 179(2):87-92. PubMed ID: 12590318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
